Followers | 12 |
Posts | 399 |
Boards Moderated | 0 |
Alias Born | 02/18/2020 |
Wednesday, January 19, 2022 11:28:38 AM
which my opinion is should be easy to do as the benefits over current treatments are numerous. selling it should be cake walk if there is a good cost comparison.
Another benefit is they can always get more money from the parent company to fund any worthwhile selling efforts. I find it hard to believe they will fail if they can execute, hope they can
I expect regnum will put a some PR on how they are going to expand and lay groundwork for introducing this HIV drug.
currently a clean, current, pink stock at $22mil+ market cap, I like that as a base, if they do any good moves in HIV medical this will go over $100 mil market cap, lets hope for execution and then performance
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM